Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-06

Clinical Trial Update: Effect of Consumption of Pep19 on Quality of Life [NA]

View source ↗

Summary

This document reports a completed clinical trial evaluating the effect of Pep19 consumption on quality of life in individuals with obesity, including sleep qual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pep19

Snippet

Sponsor: Proteimax Biotechnology Israel LTD | Conditions: Quality of Life, Obesity | NA | Status: COMPLETED